From: Evidence for treatment with estradiol for women with SARS-CoV-2 infection
Women 15–49 years Oral contraception
Patients in cohort
Odds ratio [95% CI]
Hazard ratio [95% CI]
User
2078
1.0 [0.41–2.4]
0.28 [0.1–1.1]
Non-user
16,814